{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-006954","form_type":"8-K","ticker":"TVGN","cik":"0001860871","company_name":"Tevogen Bio Holdings Inc.","filed_at":"2023-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.228610+00:00","generated_at":"2026-06-20T08:31:40.424035+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Semper Paratus corrects trust account amount in proxy; per-share value $10.34 as of Dec 31, 2022","bullets":["Corrects typographical error: trust account per-share value is $10.34 as of Dec 31, 2022, up from $10.20 as of Sep 30, 2022.","Trust account balance approximately $256.35686 million as of record date Dec 31, 2022; prior filings had outdated figures.","EGM for extension vote remains scheduled for Feb 3, 2023; no change to business combination timeline.","If extension fails, liquidation yields $10.34 per share; warrants expire worthless."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-006954","json":"https://secwatch.observer/filing/0001104659-23-006954.json","markdown":"https://secwatch.observer/filing/0001104659-23-006954.md","text":"https://secwatch.observer/filing/0001104659-23-006954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860871/000110465923006954/0001104659-23-006954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860871/000110465923006954/tm2212817d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T08:31:40.424035+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}